Atlas Trials

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

Clinical trial NCT03190304 · COMPLETED

Trial details

NCT number
NCT03190304
Sponsor
University of Sao Paulo General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Heart FailureExercise ToleranceVasodilationBody CompositionMuscle Strength
Start date
2017-06-14
Primary completion
2020-09-14
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.